Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 January 2008

Thorax. Published Online First: 3 August 2007. doi:10.1136/thx.2007.082602
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society.

Papers

Randomised placebo-controlled trial of non-invasive ventilation for hypercapnia in cystic fibrosis

Alan C Young 1*, John Wilson 2, Tom Kotsimbos 1 and Matthew Naughton 3

1 The Alfred Hospital, Australia
2 Monash University, Australia
3 Alfred Hospital, Australia

* To whom correspondence should be addressed. E-mail: alan.young{at}med.monash.edu.au.

Accepted 2 July 2007


Abstract

Background: The clinical benefits of domiciliary non-invasive positive pressure ventilation (NIV) have not been established in cystic fibrosis (CF). We studied the effects of nocturnal NIV on quality of life (QoL), functional and physiological outcomes in CF subjects with awake hypercapnia (PaCO2> 45 mmHg).

Methods: In a randomised, placebo-controlled, crossover study eight CF subjects with mean (SD) age 37 (8) years, BMI 21.1 (2.6) kg/m2, FEV1 35 (8) % predicted and PaCO2 52 (4) mmHg received six weeks of nocturnal (1) air (placebo), (2) oxygen and (3) NIV. The primary outcome measures were CF-specific QoL, daytime sleepiness and exertional dyspnoea. Secondary outcome measures were awake and asleep gas exchange, sleep architecture, lung function and peak exercise capacity.

Results: Compared to air, NIV improved the chest symptom score in the CFQoL Questionnaire (mean difference, 10; 95% CI, 5 to 16; p=0.002) and the transitional dyspnoea index score (mean difference, 3.1; 95% CI, 1.2-5.0; p=0.01). It reduced maximum nocturnal PtcCO2 (mean difference, -17mmHg; 95%CI, -7 to -28 mmHg; p=0.005) and increased exercise performance on the Modified shuttle test (mean difference, 83m; 95% CI, 21 to 144m; p=0.02). NIV did not improve sleep architecture, lung function or awake PaCO2.

Conclusion: Six weeks of nocturnal NIV improves chest symptoms, exertional dyspnoea, nocturnal hypoventilation and peak exercise capacity in stable adult CF patients with awake hypercapnia. Further studies are required to determine whether or not NIV can improve survival.

Keywords: cystic fibrosis, hypercapnia, non-invasive ventilation, oxygen, quality of life


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Balfour-Lynn, I M, Field, D J, Gringras, P, Hicks, B, Jardine, E, Jones, R C, Magee, A G, Primhak, R A, Samuels, M P, Shaw, N J, Stevens, S, Sullivan, C, Taylor, J A, Wallis, C, on behalf of the Paediatric Section of the Home Ox, (2009). BTS guidelines for home oxygen in children. Thorax 64: ii1-ii26 [Full Text]  
  • Noone, P. G (2008). Non-invasive ventilation for the treatment of hypercapnic respiratory failure in cystic fibrosis. Thorax 63: 5-7 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs